Atrás
Precio CARsgen Therapeutics Holdings Limited (02171.HK)
Gráfico del Precio de Acciones 02171.HK
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Limited
HK$16.19
-1.22%
$-0.19
Mercado cerrado: Jan 16, 16:00:00 HKT
Estadísticas clave
Cierre Anterior
$16.39
Precio de apertura
$16.39
Rango del día
$15.87 - $16.6
Rango de 52 semanas
$8.5 - $25.6
Volumen
1.3M
Volumen promedio
1.7M
EPS (TTM)
-1.06
Rendimiento de dividendos
--
Cap. de mercado
$8.8B
¿Qué es CARSGEN-B?
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved